Trial Profile
Conversion to prolonged release tacrolimus formulation in stable kidney transplant recipients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 16 Dec 2015 New trial record